Skip to content

Pharvaris

US · PHVS #2729 by market cap Listed 2021
31.68 +0.56 +1.80%
Live - 5344 symbols - heartbeat 116s ago · 2026-10-07 19:54
After-hours 31.68 0.00%
Market cap
2.22B
P/B
6.60
EPS
-3.33
Reader sentiment Are you bullish or bearish on PHVS?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/6/15
  • Rating change
    A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $46 to $74
    Market Newswire · 2026/5/13
  • H.C. Wainwright Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/9/22
  • Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $62
    Market Newswire · 2026/10/5
  • Rating change
    BofA Securities Maintains Pharvaris(PHVS.US) With Hold Rating, Raises Target Price to $35
    Market Newswire · 2026/7/29
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)
    TipRanks · 2026/5/10
  • Rating change
    Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/6/25
  • Rating change
    Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Cuts Target Price to $30.4
    Market Newswire · 2026/5/18
  • Rating change
    A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $38 to $55
    Market Newswire · 2026/8/13
  • Rating change
    A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $44 to $79
    Market Newswire · 2026/9/10
  • Rating change
    JonesTrading Maintains Pharvaris(PHVS.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/4/16
  • Form 144(Amend) | Pharvaris(PHVS.US) Officer Proposes to Sell 7 Million in Common Stocks
    Market Newswire · 2026/9/23
  • Rating change
    JonesTrading Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $52
    Market Newswire · 2026/8/29
  • Rating change
    Wedbush Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/5/13
  • Pharvaris (PHVS) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/9/22
  • Rating change
    Oppenheimer Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/5/13
  • Rating change
    BofA Securities Maintains Pharvaris(PHVS.US) With Hold Rating, Raises Target Price to $33
    Market Newswire · 2026/5/14
  • Form 144 | Pharvaris(PHVS.US) Officer Proposes to Sell 3.5 Million in Common Stocks
    Market Newswire · 2026/9/18
  • Rating change
    Wells Fargo Initiates Pharvaris(PHVS.US) With Buy Rating, Announces Target Price $55
    Market Newswire · 2026/7/15
  • Rating change
    Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/9/8

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.